KLOXXADO is a prescription 8 mg naloxone nasal spray designed for the emergency treatment of opioid overdose. The agreement expands Emergent's portfolio of life-saving opioid overdose treatments ...

(RTTNews) - Hikma Pharmaceuticals plc (HIK, HIK.L) announced Tuesday that it has entered an exclusive commercial partnership with Emergent BioSolutions for the sale of KLOXXADO naloxone HCl nasal ...

Vistagen , a late clinical-stage company dedicated to pioneering neuroscience based on nose-to-brain neurocircuitry, today announced positive results from an exploratory Phase 2A study of PH284 in ...

The ministry plans to establish a national bio committee to better support the advanced biology industry and come up with a five-year plan in the second half of the year to foster the quantum ...

A new study from Poland has found that human mast cells can secrete sclerostin, a bone metabolism regulatory protein, and that patients with advanced systemic mastocytosis (SM) have significantly ...

After hours: January 17 at 5:44:00 PM EST Loading Chart for TECH ...

After hours: January 17 at 7:46:48 PM EST Loading Chart for BKYI ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

Physical activity and prognosis and factors associated with low physical activity in patients with advanced or recurrent lung cancer: a retrospective, observational study ...